title: Fluvoxamine and graded psychotherapy in the treatment of bulimia nervosa: a randomized, double-blind, placebo-controlled, multicenter study of short-term and long-term pharmacotherapy combined with a stepped care approach to psychotherapy.
authors.forename: Ulrike
authors.initials: U
authors.lastname: Schmidt
authors.forename: Peter J
authors.initials: PJ
authors.lastname: Cooper
authors.forename: Hans
authors.initials: H
authors.lastname: Essers
authors.forename: Christopher P L
authors.initials: CP
authors.lastname: Freeman
authors.forename: Robert L
authors.initials: RL
authors.lastname: Holland
authors.forename: Robert L
authors.initials: RL
authors.lastname: Palmer
authors.forename: Eric
authors.initials: E
authors.lastname: Shur
authors.forename: Gerald F M
authors.initials: GF
authors.lastname: Russell
authors.forename: Clare
authors.initials: C
authors.lastname: Bowler
authors.forename: Sian
authors.initials: S
authors.lastname: Coker
authors.forename: John R
authors.initials: JR
authors.lastname: Geddes
authors.forename: Fiona
authors.initials: F
authors.lastname: Mackenzie
authors.forename: Jenny
authors.initials: J
authors.lastname: Munro
authors.forename: Richard
authors.initials: R
authors.lastname: Newton
authors.forename: Jane
authors.initials: J
authors.lastname: Tiller
authors.forename: Mark L
authors.initials: ML
authors.lastname: Tattersall
authors.forename: Christine
authors.initials: C
authors.lastname: Vize
authors.forename: Jenny
authors.initials: J
authors.lastname: Webster
mesh_terms: D000293:Adolescent; D000328:Adult; D002032:Bulimia / Q000628:therapy*; D003131:Combined Modality Therapy; D004311:Double-Blind Method; D004830:Epilepsy, Tonic-Clonic / Q000139:chemically induced; D005260:Female; D016666:Fluvoxamine / Q000009:adverse effects / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D008134:Long-Term Care; D008875:Middle Aged; D011446:Prospective Studies; D011614:Psychotherapy, Brief; D018570:Risk Assessment; D055502:Secondary Prevention; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016666:Fluvoxamine; D017367:Selective Serotonin Reuptake Inhibitors